Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy.
about
Intravesical chemotherapy in non-muscle-invasive bladder cancerExternal validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy.
P2860
Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Comparison of expected treatme ...... ith intravesical chemotherapy.
@en
Comparison of expected treatme ...... ith intravesical chemotherapy.
@nl
type
label
Comparison of expected treatme ...... ith intravesical chemotherapy.
@en
Comparison of expected treatme ...... ith intravesical chemotherapy.
@nl
prefLabel
Comparison of expected treatme ...... ith intravesical chemotherapy.
@en
Comparison of expected treatme ...... ith intravesical chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of expected treatme ...... ith intravesical chemotherapy.
@en
P2093
Christien T M Caris
J Alfred Witjes
Joan Palou
Maria H D Janzing-Pastors
Rianne J M Lammers
Wim P J Witjes
P2860
P304
P356
10.1111/BJU.12495
P577
2014-08-01T00:00:00Z